• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺类癌肿瘤切除术后的预后因素:一项长达10年随访的回顾性研究。

Prognostic factors in resected pulmonary carcinoid tumors: A retrospective study with 10 years of follow‑up.

作者信息

Du Lin, Ernani Vinicius, Liu Alex, Schild Steven E, Jaroszewski Dawn E, Cassivi Steven D, Beamer Staci E, Luo Yung-Hung, Wampfler Jason A, Santos Pedro A Reck Dos, Wigle Dennis, Sun Daqiang, Shen K Robert, Yang Ping

机构信息

Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin 300222, P.R. China.

Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85260, USA.

出版信息

Oncol Lett. 2023 Jan 10;25(2):80. doi: 10.3892/ol.2023.13666. eCollection 2023 Feb.

DOI:10.3892/ol.2023.13666
PMID:36742364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9853094/
Abstract

The objective of the present study was to characterize the difference in 10-year carcinoid-specific survival (CSS) and disease-free survival (DFS) among patients with resected pulmonary typical carcinoid (TC) and atypical carcinoid (AC). Patients diagnosed with pulmonary carcinoid tumors (PCT) between January 1, 1997, and December 31, 2016, were identified. All patients underwent video-assisted thoracoscopic surgery or thoracotomy with thoracic lymphadenectomy. Cumulative CSS was estimated using the Kaplan-Meier model. The analysis of hazard ratios (HRs) and 95% confidence intervals (CIs) was performed using univariate and multivariate Cox proportional hazards models. A total of 404 patients with PCT were included in the present study. The 10-year CSS and DFS rates of patients with AC were significantly worse than those of patients with TC (49.1 vs. 86.8% and 52.2 vs. 92.6%, respectively; P<0.001). In the CSS multivariate analysis, older age and lymph node involvement (HR, 2.45; P=0.022) were associated with worse survival in AC, while age, male sex, M1 stage, cigarette smoking and inadequate N2 lymphadenectomy were associate with worse survival in TC. In the recurrence multivariate analysis, N1-3 stage (HR, 2.62; 95% CI, 1.16-5.95; P=0.018) and inadequate N2 lymphadenectomy (HR, 2.13; 95% CI, 1.04-4.39; P=0.041) were associated with an increase in recurrence in AC, while male sex (HR, 3.72; 95% CI, 1.33-10.42; P=0.010) and M1 stage (HR, 14.93; 95% CI, 4.77-46.77; P<0.001) were associated with an increase in recurrence in TC. In conclusion, patients with AC tumors had significantly worse CSS and DFS rates compared with patients with TC. The degree of nodal involvement in AC was a prognostic marker, in contrast to that in TC. Inadequate lymphadenectomy increased the risk of recurrence in AC and mortality in TC, although surgical approaches did not have a significant impact. The present study therefore emphasizes the importance of mediastinal nodal dissection in patients with PCTs.

摘要

本研究的目的是描述接受手术切除的肺典型类癌(TC)和非典型类癌(AC)患者10年类癌特异性生存率(CSS)和无病生存率(DFS)的差异。确定了1997年1月1日至2016年12月31日期间诊断为肺类癌肿瘤(PCT)的患者。所有患者均接受了电视辅助胸腔镜手术或开胸手术及胸段淋巴结清扫术。使用Kaplan-Meier模型估计累积CSS。使用单因素和多因素Cox比例风险模型进行风险比(HRs)和95%置信区间(CIs)分析。本研究共纳入404例PCT患者。AC患者的10年CSS和DFS率显著低于TC患者(分别为49.1%对86.8%和52.2%对92.6%;P<0.001)。在CSS多因素分析中,年龄较大和淋巴结受累(HR,2.45;P=0.022)与AC患者较差的生存率相关,而年龄、男性、M1期、吸烟和N2淋巴结清扫不充分与TC患者较差的生存率相关。在复发多因素分析中,N1-3期(HR,2.62;95%CI,1.16-5.95;P=0.018)和N2淋巴结清扫不充分(HR,2.13;95%CI,1.04-4.39;P=0.041)与AC患者复发增加相关,而男性(HR,3.72;95%CI,1.33-10.42;P=0.010)和M1期(HR,14.93;95%CI,4.77-46.77;P<0.001)与TC患者复发增加相关。总之,与TC患者相比,AC肿瘤患者的CSS和DFS率显著更差。与TC不同,AC中淋巴结受累程度是一个预后标志物。淋巴结清扫不充分增加了AC患者复发风险和TC患者死亡风险,尽管手术方式没有显著影响。因此,本研究强调了纵隔淋巴结清扫在PCT患者中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea68/9853094/be0ed54c1105/ol-25-02-13666-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea68/9853094/d4fe13c51bfc/ol-25-02-13666-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea68/9853094/be0ed54c1105/ol-25-02-13666-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea68/9853094/d4fe13c51bfc/ol-25-02-13666-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea68/9853094/be0ed54c1105/ol-25-02-13666-g01.jpg

相似文献

1
Prognostic factors in resected pulmonary carcinoid tumors: A retrospective study with 10 years of follow‑up.肺类癌肿瘤切除术后的预后因素:一项长达10年随访的回顾性研究。
Oncol Lett. 2023 Jan 10;25(2):80. doi: 10.3892/ol.2023.13666. eCollection 2023 Feb.
2
Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.肺类癌的外科切除:多中心研究的长期结果-病理 N 状态的重要性,超乎我们想象。
Lung. 2017 Dec;195(6):789-798. doi: 10.1007/s00408-017-0056-8. Epub 2017 Oct 11.
3
Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases.类癌淋巴结转移的发生率和预后意义。
Ann Thorac Surg. 2018 Oct;106(4):981-988. doi: 10.1016/j.athoracsur.2018.05.044. Epub 2018 Jun 15.
4
Segmentectomy and wedge resection are equivalent for the treatment of early-stage pulmonary carcinoid tumors: A retrospective cohort study.肺段切除术和楔形切除术治疗早期肺类癌肿瘤效果相当:一项回顾性队列研究
Sci Rep. 2024 Jul 31;14(1):17742. doi: 10.1038/s41598-024-68695-y.
5
Predictive Indicators of Survival in Patients With Surgically Resected Lung Carcinoid Tumors at a Greek Medical Center.希腊某医疗中心手术切除的肺类癌肿瘤患者生存的预测指标
Cureus. 2020 Sep 7;12(9):e10300. doi: 10.7759/cureus.10300.
6
Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors.手术切除支气管类癌肿瘤患者无病生存期和复发的预测因素
Thorac Cardiovasc Surg. 2016 Mar;64(2):159-65. doi: 10.1055/s-0035-1544211. Epub 2015 Mar 10.
7
Role of wedge resection in bronchial carcinoid (BC) tumors: SEER database analysis.楔形切除术在支气管类癌(BC)肿瘤中的作用:监测、流行病学和最终结果(SEER)数据库分析
J Thorac Dis. 2019 Apr;11(4):1355-1362. doi: 10.21037/jtd.2019.03.89.
8
Lung parenchymal invasion in pulmonary carcinoid tumor: an important histologic feature suggesting the diagnosis of atypical carcinoid and poor prognosis.肺类癌肿瘤中的肺实质侵犯:提示非典型类癌和预后不良的重要组织学特征。
Lung Cancer. 2013 May;80(2):146-52. doi: 10.1016/j.lungcan.2013.01.005. Epub 2013 Feb 4.
9
Recurrence Rates and Patterns after Radical Resection of Lung Carcinoids.肺类癌根治性切除术后的复发率及模式
Cancers (Basel). 2024 Aug 27;16(17):2978. doi: 10.3390/cancers16172978.
10
Value of [Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature.[镓]镓-生长抑素受体PET/CT在肺神经内分泌(类癌)肿瘤分级及播散性疾病检测中的价值:基于单中心病理的分析及文献综述
EJNMMI Res. 2022 May 7;12(1):28. doi: 10.1186/s13550-022-00900-3.

引用本文的文献

1
Surgical management of both stage III and stage IV pulmonary carcinoid tumors confers survival benefit.III期和IV期肺类癌肿瘤的手术治疗均能带来生存获益。
JTCVS Open. 2025 Jun 18;26:218-233. doi: 10.1016/j.xjon.2025.06.005. eCollection 2025 Aug.

本文引用的文献

1
A National Study of Surgically Managed Atypical Pulmonary Carcinoid Tumors.全国范围内手术治疗非典型性肺类癌肿瘤的研究。
Ann Thorac Surg. 2021 Sep;112(3):921-927. doi: 10.1016/j.athoracsur.2020.09.029. Epub 2020 Nov 4.
2
The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database.手术在非典型支气管肺类癌肿瘤中的作用:基于监测、流行病学和最终结果(SEER)数据库的模型的建立和验证。
Lung Cancer. 2020 Jan;139:94-102. doi: 10.1016/j.lungcan.2019.11.006. Epub 2019 Nov 14.
3
Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases.
类癌淋巴结转移的发生率和预后意义。
Ann Thorac Surg. 2018 Oct;106(4):981-988. doi: 10.1016/j.athoracsur.2018.05.044. Epub 2018 Jun 15.
4
Prognostic Factors in Typical and Atypical Pulmonary Carcinoids.典型和非典型肺类癌的预后因素
Ochsner J. 2017 Winter;17(4):335-340.
5
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.非小细胞肺癌临床实践指南(2017 年第 5 版),NCCN 肿瘤学临床实践指南
J Natl Compr Canc Netw. 2017 Apr;15(4):504-535. doi: 10.6004/jnccn.2017.0050.
6
Outcomes after surgical resection of pulmonary carcinoid tumors.肺类癌肿瘤手术切除后的结果。
J Cardiothorac Surg. 2016 Mar 2;11:35. doi: 10.1186/s13019-016-0424-0.
7
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.2015 年世界卫生组织肺肿瘤分类:自 2004 年分类以来遗传、临床和放射学进展的影响。
J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630.
8
Long-term outcomes and prognostic factors of patients with pulmonary carcinoid tumors.肺类癌肿瘤患者的长期预后及预后因素
Neoplasma. 2015;62(3):478-83. doi: 10.4149/neo_2015_057.
9
Atypical carcinoid tumours of the lung: prognostic factors and patterns of recurrence.肺非典型类癌肿瘤:预后因素和复发模式。
Thorax. 2014 Jul;69(7):648-53. doi: 10.1136/thoraxjnl-2013-204102. Epub 2014 Mar 6.
10
Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance.肺类癌肿瘤切除术后复发:对术后监测的影响。
Ann Thorac Surg. 2013 Oct;96(4):1156-1162. doi: 10.1016/j.athoracsur.2013.05.047. Epub 2013 Jul 31.